08 Jun 2026 Development toward clinical application of AdoShell®, an encapsulation system for pancreatic islet transplantation, Poster, June 5, 2026, 86th Scientific Sessions ADA 2026, New Orleans, USA Icon check
08 Jun 2026 AdoXLong platform applied to semaglutide for once-monthly administration, Poster, June 5, 2026, 86th Scientific Sessions ADA 2026, New Orleans, USA Icon check
08 Jun 2026 Ultra-Rapid TDB0206 Injection (BioChaperone Lispro, BCLIS) Improves Postprandial And Daily Glucose Control Vs. Lispro (LIS) In Chinese People With Type 2 Diabetes (T2D), Poster, June 5, 2026, 86th Scientific Sessions ADA 2026, New Orleans, USA Icon check
General Shareholders Meeting – June 3, 2026 (FR)
Olivier Soula and Stéphane Boissel interview – La bourse et la vie – May 2026
22 Mar 2026 AdOral®—A Versatile Platform for Improved Oral Peptide Absorption, Poster, Dr Martin Gaudier, 18th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2025), Amsterdam, Netherlands Icon check
Interview Stéphane Boissel – Chairman of the Board – March 2026
Olivier Soula and Mathieu-William Gilbert – Presentation Investir Day November 2025 (FR)
27 Oct 2025 Stable co-formulation of cagrilintide and semaglutide enabled by the BioChaperone® technology for multi-dose pen injectors, Poster, October 27, 2025, PODD 2025, Boston, USA Icon check
Interview Olivier Soula – Bourse et Valeurs – July 2025 (FR)
16 Jun 2025 AdoShell®, a non-fibrotic encapsulation system for human islet transplantation without immunosuppression, Oral Presentation, Dr Anne-Lise Gaffuri, 20th World Congress of the international pancreas and islet transplant association (IPITA 2025) Icon check
General Shareholders Meeting – June 11, 2025 (FR)
12 Jun 2025 Adoshell®: a permselective and non-fibrotic scaffold for human islet transplantation, Poster, Dr Clément Cocita, European islet study group 2025, Malmö, Sweden Icon check
02 Apr 2025 Développement d’AdoGel®, un hydrogel injectable permettant une libération prolongée de semaglutide sur un mois, Short Oral Presentation, Dr Audrey Maréchal, Congrès annuel de la SFD 2025 Icon check
02 Apr 2025 AdoShell®, un nouveau biomatériau pour la transplantation d’ilots, Short Oral Presentation, Camille Gautier, Congrès annuel de la SFD 2025 Icon check
20 Mar 2025 AdoShell®, a non-fibrotic immunoprotective hydrogel shows efficient and sustained in vivo functionality for clinical use, Oral Presentation, Dr Anne-Lise Gaffuri, 18th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2025), Amsterdam, Netherlands Icon check
28 Jan 2025 AdoShell®, a non-fibrotic immunoprotective hydrogel containing human islets shows efficient and sustained in vivo functionality for clinical use, Oral Presentation, Dr Ouardane Jouannot, 14th EPITA Symposium, Pisa, Italy Icon check
Olivier Soula – Bourse et Valeurs, Lyon Pole Bourse 2024 (FR)
13 Sep 2024 Development of a once-a-month formulation of Semaglutide from an innovative injectable and biodegradable hydrogel, Short Oral Presentation, Dr Claire Mégret, 60th annual meeting, EASD 2024, Madrid, Spain Icon check
10 Sep 2024 ADO12, a non-fibrotic immunoprotective hydrogel containing human islets shows efficient and sustained in vivo functionality for clinical use, Oral Presentation, Dr Anne-Lise Gaffuri, 60th annual meeting, EASD 2024, Madrid, Spain Icon check
Web Conference – BioChaperone Combo – July 2024 (FR)
22 Jun 2024 Development of a once-a-month formulation of Semaglutide from an innovative injectable and biodegradable hydrogel, Poster, Dr Olivier Soula, 84th scientific Sessions, ADA 2024, Orlando, USA Icon check
22 Jun 2024 AdOral ®—A Versatile Platform for Improved Oral Peptide Absorption, Poster, Dr Ouardane Jouannot, 84th scientific Sessions, ADA 2024, Orlando, USA Icon check
22 Jun 2024 AdoShell®, a non fibrotic, immunoprotective encapsulation system for human islets transplantation shows promising results for clinical application as a cure for people with Type 1 Diabetes, Poster, Dr Ouardane Jouannot, 84th scientific Sessions, ADA 2024, Orlando, USA Icon check
Interview Olivier Soula – La France de Demain, Radio Classique – May 2024 (FR)
Olivier Soula – LSX World Congress – April 2024
Interview Olivier Soula – Le Journal des Biotechs – March 2024 (FR)
22 Mar 2024 AdoShell®, un nouveau biomatériau pour la transplantation d’ilots, Oral Presentation, Dr Rosy Eloy, Congrès annuel de la SFD 2024 Icon check
BIO-Europe Spring 2024: Interview with Jérémy Benattar
Web-conference – 4th Quarter 2023 Financial Results (FR)
Olivier Soula – Le Revenu TV – Dec. 2023 (FR)
Web conférence – Diabète : un laboratoire pour le futur de la santé – déc. 2023 (FR)
Olivier Soula – Investival Showcase
28 Oct 2023 How to deliver a therapeutic dose of encapsulated human islets? , Oral Presentation, Dr Rosy Eloy, IPITA-IXA-CTRMS Joint Congress 2023, San Diego, USA Icon check
Jérémy Benattar – Investisseur.TV (FR)
Olivier Soula – Bourse et Valeurs, Lyon Pole Bourse (FR)
05 Oct 2023 ADO12, a new allogenic islet encapsulation device for islet transplantation without immunosuppression, Oral Presentation, Dr Anne-Lise Gaffuri, 59th annual meeting, EASD 2023, Hamburg, Germany Icon check
11 Jul 2023 EndoC-bH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion. Mol Metab. 2023 Jul 11;76:101772 Icon check
Webconference of July 6th, 2023
23 Jun 2023 AdoShell® Islets, a new biomaterial for allogenic islet encapsulation, shows 6 months insulin secretion in diabetic immunocompetent rats, Dr. Ouardane Jouannot, June 23, 2023, 83rd scientific Sessions, ADA 2023
23 Jun 2023 AdoShell® Islets shows long-term in vitro and in vivo survival and functionality of encapsulated pancreatic islets, Oral Presentation, Dr Ouardane Jouannot, 83rd scientific Sessions, ADA 2023, San Diego, USA Icon check
2022 Annual Results
Join our mailing list. Subscribe